-
Document de presse | 2004.02.19
Institut Pasteur/ Inserm : Joint research on the Nipah virus
Two teams from the Institut Pasteur and Inserm, in co-operation with Malaysian researchers, have recently successfully tested a candidate vaccine against the Nipah Virus. This virus, still undiscovered in 1998, was responsible for the deaths of 105 people in Malaysia in 1999. It is expanding at an alarming speed in South-East Asia. Currently there is no treatment in the fight against this...
-
Document de presse | 2004.01.28
France/China : Real cooperation in the field of infectious diseases with the plan for an Institut Pasteur in China
Within the context of French-Chinese cooperation, which has expanded on the occasion of President Hu Jintao's state visit, health is one of the most important sectors. A declaration of intent on the prevention of and fight against emerging infectious diseases was signed yesterday at Matignon by Ms. Claudie Haigneré and Jean François Mattei, and Mr. Yan Hua Liu, deputy minister of Science and...
-
Document de presse | 2004.01.20
World Leprosy Day (25 January): The Institut Pasteur develops new diagnostic testsand epidemiological tools
According to the World Health Organisation, 2.8 million people throughout the world are infected with leprosy, and each year about 750,000 new cases are recorded. Since the leprosy bacillus genome was sequenced in 2001 by the team directed by Stewart Cole of the Institut Pasteur , important advances have been made. New diagnostic tests and epidemiological tools are currently being developed in...
-
Document de presse | 2004.01.19
A major advance in combatting Buruli ulcer
An international group of scientists coordinated by Stewart Cole of the Institut Pasteur has just discovered the genetic basis for the synthesis of the Mycobacterium ulcerans toxin, responsible for Buruli ulcer. Press release Paris, january 20, 2004 A rapidly-expanding emerging disease, Buruli ulcer is the one of the most common mycobacterial infections after...
-
Document de presse | 2011.04.30
The Institut Pasteur celebrates 50 years of molecular biology
May 2011 - Press kit Contents > A symposium for a very special anniversary > The heritage of a foundational discovery > The lac operon in short > Lwoff, Jacob, and Monod – portraits of three pioneers Download the press kit > Press kit (PDF)
-
Document de presse | 2013.05.28
Worldwide Outbreak of Highly Antibiotic-Resistant Salmonella Risks Spreading to European Poultry Farms
In a study published online May 28th for the Lancet Infectious Diseases medical journal, scientists at the Institut Pasteur in Paris and the Institut Pasteur in Morocco once again bring attention to the rapid worldwide spread of Salmonella Kentucky (S. Kentucky), a bacterium showing resistance to several classes of antibiotics. S. Kentucky is responsible for foodborne infections and has spread at...
-
Document de presse | 2013.07.04
Transmissibility of new coronavirus too low to trigger global epidemic at this stage
In a study published online on July 5, 2013 for the medical journal The Lancet, a team from the Institut Pasteur suggests that the coronavirus MERS-CoV, in its current form, is not capable of triggering a global epidemic. However, it should not be assumed that the virus’ transmissibility will not increase if the virus mutates or if transmission occurs at a one-off event where large numbers...
-
Document de presse | 2013.08.01
Dengue: identifying mosquito genetic factors that control virus transmission
Dengue is currently the most common insect-borne viral disease of humans worldwide. Scientists from the Institut Pasteur, the French National Center for Scientific Research (CNRS), and the Armed Forces Research Institute of Medical Sciences (AFRIMS) have discovered several genetic factors controlling the transmission of various dengue virus strains in a natural population of mosquitoes in...
-
Document de presse | 2013.08.25
Neutrophils: the Unsung Heroes of Immunotherapy Cancer Treatment
Scientists at the Institut Pasteur and Inserm have identified the group of cells within the immune system that make immunotherapy treatment (therapeutic antibodies) effective. Immunotherapy is frequently used to treat breast cancer. In animal models they showed that neutrophils, the most common white blood cells in the body, are not only necessary but suffice on their own to eliminate tumor cells...
-
Document de presse | 2013.09.10
A simple in vitro test to bring surveillance of artemisinin-resistant malaria parasites to scale
A fruitful international cooperation, scientists from the Institut Pasteur in Cambodia, the Institut Pasteur in Paris and the National Institutes of Health (NIH) developed the first in vitro test adapted to field conditions in malaria-endemic areas for the study of artemisinin-resistant Plasmodium falciparum (the parasite responsible for severe cases of malaria). Artemisinin is a major component...
